ABLIM3 | Actin binding LIM protein family, member 3 | Plasma proteins
| | | | | Tissue enhanced |
AC117834.1 | | | | | | | Tissue enhanced |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM23 | ADAM metallopeptidase domain 23 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADCY5 | Adenylate cyclase 5 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
ANGPTL7 | Angiopoietin-like 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
ANO5 | Anoctamin 5 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
AP001579.1 | Uncharacterized protein | | | | | | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
BCO2 | Beta-carotene oxygenase 2 | Enzymes
| | | | | Tissue enhanced |
BVES | Blood vessel epicardial substance | Predicted membrane proteins
| | | | | Tissue enhanced |
C15orf56 | Chromosome 15 open reading frame 56 | | | | | | Tissue enhanced |
C1orf170 | Chromosome 1 open reading frame 170 | | | | | | Tissue enhanced |
C1QTNF9 | C1q and tumor necrosis factor related protein 9 | Predicted secreted proteins
| | | | | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CDH13 | Cadherin 13 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH19 | Cadherin 19, type 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CHRM2 | Cholinergic receptor, muscarinic 2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CLGN | Calmegin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL21A1 | Collagen, type XXI, alpha 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
COLQ | Collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CRIP3 | Cysteine-rich protein 3 | | | | | | Tissue enhanced |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CRYM | Crystallin, mu | Enzymes
| | | | | Tissue enhanced |
CSDC2 | Cold shock domain containing C2, RNA binding | | | | | | Tissue enhanced |
CTAG2 | Cancer/testis antigen 2 | Cancer-related genes
| | | | | Tissue enhanced |
CTNNA3 | Catenin (cadherin-associated protein), alpha 3 | Disease related genes
| | | | | Tissue enhanced |
CXorf31 | Chromosome X open reading frame 31 | | | | | | Tissue enhanced |
CYP2J2 | Cytochrome P450, family 2, subfamily J, polypeptide 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
DKK3 | Dickkopf WNT signaling pathway inhibitor 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DOK7 | Docking protein 7 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DPYSL4 | Dihydropyrimidinase-like 4 | Plasma proteins
| | | | | Tissue enhanced |
DTNA | Dystrobrevin, alpha | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EBF2 | Early B-cell factor 2 | Transcription factors
| | | | | Tissue enhanced |
EEF1A2 | Eukaryotic translation elongation factor 1 alpha 2 | Plasma proteins
| | | | | Tissue enhanced |
ENAM | Enamelin | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ESRRB | Estrogen-related receptor beta | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
FAM110B | Family with sequence similarity 110, member B | | | | | | Tissue enhanced |
FGF18 | Fibroblast growth factor 18 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FHOD3 | Formin homology 2 domain containing 3 | Cytoskeleton related proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FILIP1 | Filamin A interacting protein 1 | | | | | | Tissue enhanced |
FITM2 | Fat storage-inducing transmembrane protein 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
FPGT-TNNI3K | FPGT-TNNI3K readthrough | | | | | | Tissue enhanced |
FRMD3 | FERM domain containing 3 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GATA4 | GATA binding protein 4 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GHRH | Growth hormone releasing hormone | Predicted secreted proteins
| | | | | Tissue enhanced |